MBI_Logo_Tagline_Blue.jpg
바이오라인, EPIK™ miRNA Assays 제품군 확장
January 09, 2017 22:27 ET | Meridian Bioscience, Inc.
미국 신시내티, Jan. 10, 2017 (GLOBE NEWSWIRE) -- PCR 장비 전문 기업인 바이오라인(Bioline)이 개별 마이크로RNA(miRNA) 분자 연구용으로 개발되던 EPIK™ miRNA Select Assays 제품군을 확대한다고 발표했다. 바이오라인은 메리디안 바이오사이언스(Meridian Bioscience, Inc.)(나스닥...
MBI_Logo_Tagline_Blue.jpg
Bioline Launches the Full Range of EPIK™ miRNA Assays
January 09, 2017 12:04 ET | Meridian Bioscience, Inc.
CINCINNATI, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of the EPIK™ miRNA Select...
MBI_Logo_Tagline_Blue.jpg
Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Signs Exclusive Partnership to Expand Blood Lead Testing in China
December 20, 2016 14:00 ET | Meridian Bioscience, Inc.
CINCINNATI, Dec. 20, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its Magellan Diagnostics business unit has signed an exclusive distribution agreement with...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2017 Cash Dividend Rate, and Reaffirms Fiscal 2017 Guidance
November 10, 2016 07:45 ET | Meridian Bioscience, Inc.
GENERAL HIGHLIGHTS CINCINNATI, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fourth quarter and full-year fiscal 2016 net revenues of $47.0 million...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience, Inc. Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance
October 18, 2016 16:30 ET | Meridian Bioscience, Inc.
CINCINNATI, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that based on preliminary results, it expects revenues for fiscal year 2016, ended on...
MBI_Logo_Tagline_Blue.jpg
Bioline獲ISO 13485質量標準認證
October 04, 2016 10:05 ET | Meridian Bioscience, Inc.
辛辛那提, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc.(NASDAQ代號:VIVO)旗下全資附屬公司聚合酶鏈反應(PCR)公司Bioline欣然宣佈,倫敦研發設施及柏林製造設施現已全面獲得ISO...
MBI_Logo_Tagline_Blue.jpg
바이오라인, ISO 13485 품질 인증 획득
October 04, 2016 10:05 ET | Meridian Bioscience, Inc.
미국 신시내티, Oct. 04, 2016 (GLOBE NEWSWIRE) -- PCR 장비 전문 기업인 바이오라인(Bioline)의 런던 R&D 시설과 베를린 제조시설이 ISO 13485 품질 인증을 획득했다고 발표했다. 바이오라인은 메리디안 바이오사이언스(Meridian Bioscience, Inc.)(나스닥 거래명: VIVO)의...
MBI_Logo_Tagline_Blue.jpg
Bioline ได้รับการรับรองมาตรฐานคุณภาพ ISO 13485
October 04, 2016 10:05 ET | Meridian Bioscience, Inc.
CINCINNATI, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Bioline ซึ่งเป็นบริษัท PCR รายหนึ่งที่เป็นบริษัทย่อยอยู่ในเครือ Meridian Bioscience, Inc. (NASDAQ:VIVO) มีความภูมิใจที่จะประกาศว่าโรงงานผลิตที่ลอนดอน...
MBI_Logo_Tagline_Blue.jpg
Bioline Disahkan Mematuhi Standard Kualiti ISO 13485
October 04, 2016 10:05 ET | Meridian Bioscience, Inc.
CINCINNATI, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Bioline, Syarikat PCR, anak syarikat milik penuh Meridian Bioscience, Inc. (NASDAQ:VIVO) berbangga untuk mengumumkan bahawa kemudahan R&D London...
MBI_Logo_Tagline_Blue.jpg
Bioline Memperoleh Sertifikasi Standar Kualitas ISO 13485
October 04, 2016 10:05 ET | Meridian Bioscience, Inc.
CINCINNATI, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Bioline, Perusahaan PCR, anak perusahaan yang sepenuhnya dimiliki oleh Meridian Bioscience, Inc. (NASDAQ:VIVO) dengan bangga mengumumkan bahwa fasilitas...